Drug Type Small molecule drug |
Synonyms Compound 837646(Emory University) |
Target |
Action inhibitors |
Mechanism GSK-3 inhibitors(Glycogen synthase kinase-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H21F4N3O |
InChIKeySQEIPOLPFUCYNQ-YLJYHZDGSA-N |
CAS Registry3035842-62-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Discovery | United States | 04 Apr 2025 | |
Neoplasms | Discovery | United States | 04 Apr 2025 | |
Nervous System Diseases | Discovery | United States | 04 Apr 2025 |